HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹51.03
Day range
₹51.02 - ₹52.24
Year range
₹49.20 - ₹133.00
Market cap
2.87B INR
Avg Volume
159.41K
P/E ratio
11.45
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 745.73M | 24.63% |
Operating expense | 246.17M | 37.28% |
Net income | 86.38M | -21.00% |
Net profit margin | 11.58 | -36.62% |
Earnings per share | — | — |
EBITDA | 108.72M | -18.16% |
Effective tax rate | 10.61% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 394.00M | -37.03% |
Total assets | 3.10B | 20.13% |
Total liabilities | 786.06M | 37.96% |
Total equity | 2.32B | — |
Shares outstanding | 55.37M | — |
Price to book | 1.22 | — |
Return on assets | — | — |
Return on capital | 9.75% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 86.38M | -21.00% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600
